BioTissue Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Accelerator/​Inc

  • Financing Rounds
  • 8

BioTissue General Information

Description

Provider of ortho-biological devices catering to patients and health professionals. The company offers a three-dimensional autologous chondrocyte graft to treat articular cartilage defects in the knee through guided tissue regeneration and tissue engineering, thereby providing therapies to regenerate damaged tissues or organs.

Contact Information

Formerly Known As
CeiROx Life Sciences
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 5, Rue Paul-Bouchet
  • 1201 Geneva
  • Switzerland
+41 043
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5, Rue Paul-Bouchet
  • 1201 Geneva
  • Switzerland
+41 043

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioTissue Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioTissue‘s full profile, request access.

Request a free trial

BioTissue Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of ortho-biological devices catering to patients and health professionals. The company offers a three-dimension
Therapeutic Devices
Geneva, Switzerland

Houston, TX
 

Charlottesville, VA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioTissue Competitors (7)

One of BioTissue’s 7 competitors is Synthecon, a Formerly Accelerator/Incubator backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Synthecon Formerly Accelerator/Incubator backed Houston, TX
TearSolutions Venture Capital-Backed Charlottesville, VA
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI
Augurex Venture Capital-Backed Vancouver, Canada
Clearside Biomedical Formerly VC-backed Alpharetta, GA
You’re viewing 5 of 7 competitors. Get the full list »

BioTissue Patents

BioTissue Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2940646-T3 Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or a pin Active 19-Mar-2019
ES-2957134-T3 Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or a pin Active 19-Mar-2019
EP-3833281-A1 Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or pin Active 19-Mar-2019
WO-2020187444-A1 Set for endoscopic fixation of an implant in an intervertebral disc by means of a nail or pin Inactive 19-Mar-2019
EP-3711687-A1 Set for endoscopic fixing of an implant in an intervertebral disc with a nail or pin Active 19-Mar-2019 A61B17/1757
To view BioTissue’s complete patent history, request access »

BioTissue Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioTissue‘s full profile, request access.

Request a free trial

BioTissue FAQs

  • When was BioTissue founded?

    BioTissue was founded in 1997.

  • Where is BioTissue headquartered?

    BioTissue is headquartered in Geneva, Switzerland.

  • What industry is BioTissue in?

    BioTissue’s primary industry is Therapeutic Devices.

  • Is BioTissue a private or public company?

    BioTissue is a Private company.

  • What is BioTissue’s current revenue?

    The current revenue for BioTissue is .

  • How much funding has BioTissue raised over time?

    BioTissue has raised $23.1M.

  • Who are BioTissue’s investors?

    COI Partners, DIH Deutsche Industrie Holding, and EVP Capital Management have invested in BioTissue.

  • Who are BioTissue’s competitors?

    Synthecon, TearSolutions, ONL Therapeutics, Augurex, and Clearside Biomedical are some of the 7 competitors of BioTissue.

  • When was BioTissue acquired?

    BioTissue was acquired on 01-Jan-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process